Concepedia

Yuki Hamano

YH

Statistics

Publications

16

Citations

2.4K

H-Index

15

Active since

1999

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Chiba University

Harvard University Press

Dana-Farber Cancer Institute

Yuki Hamano is an author at Beth Israel Deaconess Medical Center specializing in medicine, renal pathology, and renal pathophysiology.

Publications per year

1999–2021

16

Publications

16

Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin

Yuki Hamano, Michael Zeisberg, Hikaru Sugimoto et al. · Cancer Cell · 2003 · 552 citations · Full text

, , +10

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

Hikaru Sugimoto, Yuki Hamano, David M. Charytan et al. · Journal of Biological Chemistry · 2003 · 532 citations · Full text

, , +17

Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia

Keizo Kanasaki, Kristin Palmsten, Hikaru Sugimoto et al. · Nature · 2008 · 379 citations

, , +8

Thrombospondin-1 Associated with Tumor Microenvironment Contributes to Low-Dose Cyclophosphamide-Mediated Endothelial Cell Apoptosis and Tumor Growth Suppression

Yuki Hamano, Hikaru Sugimoto, Mary A. Soubasakos et al. · Cancer Research · 2004 · 187 citations · Full text

, , +16

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors

Malin Sund, Yuki Hamano, Hikaru Sugimoto et al. · Proceedings of the National Academy of Sciences · 2005 · 179 citations · Full text

, , +14

1–5 of 16